Quick Answer
Barinthus Biotherapeutics plc. reported Shares Outstanding of 40.85 million shares for fiscal year 2025.
Barinthus Biotherapeutics plc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 40.85M | +1.5% |
| 2024 | 40.23M | +4.1% |
| 2023 | 38.64M | +2.5% |
| 2022 | 37.68M | +1.3% |
| 2021 | 37.19M | +367.2% |
| 2020 | 7.96M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 40.83M | +3.2% | +1.2% |
| June 30, 2025 | 40.35M | +3.0% | +0.0% |
| March 31, 2025 | 40.34M | +3.6% | +0.3% |
| December 31, 2024 | 40.23M | +4.1% | +1.8% |
| September 30, 2024 | 39.54M | +2.6% | +0.9% |
| June 30, 2024 | 39.18M | +1.7% | +0.6% |
| March 31, 2024 | 38.95M | +1.6% | +0.8% |
| December 31, 2023 | 38.64M | +2.5% | +0.3% |
- Barinthus Biotherapeutics plc. showed an increase of +1.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Barinthus Biotherapeutics plc.’s shares outstanding has grown by 413.1% (from 7.96 million shares to 40.85 million shares).
- The most recent figure is from Barinthus Biotherapeutics plc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: